http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IL-51988-A0

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2817954cd008bcd609a4c4eb49050be
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-685
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 1977-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1977-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber IL-51988-A0
titleOfInvention Tumor antidotes comprising lysolecithin analogs
priorityDate 1976-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426222304
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16081932

Total number of triples: 15.